| Connected Entity | Relationship Type |
Strength
(mentions)
|
Documents | Actions |
|---|---|---|---|---|
|
person
The Board (NLRB)
|
Adversarial critical |
7
|
1 |
An internal email dated August 1, 2019, discussing Inmate Epstein's return from court the previous day. A staff member in R & D reported that Epstein signed a form with the Marshals noting 'Suicidal tendencies,' although the staff member denied the form explicitly stated he was suicidal. The sender asks for guidance on whether to see the inmate or perform a Suicide Risk Assessment (SRA).
This document is an internal note from a correctional facility (likely MCC New York) regarding Jeffrey Epstein's return from court. It details a dispute over a form signed with US Marshals which Epstein claimed noted 'Suicidal tendencies,' while another party denied this. The author asks if they should perform a Suicide Risk Assessment (SRA).
This document is a page from the Federal Register dated August 30, 2011, discussing a proposed rule from the National Labor Relations Board (NLRB) and the Board's response to public comments. Various business associations and law firms raised concerns about the compliance costs and economic impact on small businesses, particularly regarding legal fees and requirements for electronic notice posting. Despite the user's prompt, this document has no discernible connection to Jeffrey Epstein; it is a regulatory document concerning U.S. labor law.
This document is a page from the Federal Register dated August 30, 2011, detailing the National Labor Relations Board's (NLRB) justification for a new rule requiring employers to post notices of employee rights. The NLRB concludes the rule will not have a significant economic impact on small businesses, estimating the cost at $64.40, and refutes critical comments from organizations like Baker & Daniels LLP. Despite the user's prompt suggesting a link to Epstein, the document's content is exclusively about U.S. labor law and contains no information related to Jeffrey Epstein or his associates.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity